Free Trial

Neumora Therapeutics (NMRA) Earnings Date, Estimates & Call Transcripts

$9.17
-0.14 (-1.50%)
(As of 05/24/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 6Estimated
Actual EPS
(May. 7)
-$0.34
Consensus EPS
(May. 7)
-$0.34
Skip Charts & View Estimated and Actual Earnings Data

NMRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NMRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neumora Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.56)($1.56)($1.56)
Q2 20241($1.59)($1.59)($1.59)
Q3 20241($0.37)($0.37)($0.37)
Q4 20241($1.28)($1.28)($1.28)
FY 20244($4.80)($4.80)($4.80)
Q1 20251($0.38)($0.38)($0.38)
Q2 20251($0.39)($0.39)($0.39)
Q3 20251($0.39)($0.39)($0.39)
Q4 20251($0.40)($0.40)($0.40)
FY 20254($1.56)($1.56)($1.56)

NMRA Earnings Date and Information

Neumora Therapeutics last posted its earnings results on May 7th, 2024. The reported ($0.34) EPS for the quarter, hitting analysts' consensus estimates of ($0.34). Neumora Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Neumora Therapeutics are expected to decrease in the coming year, from ($1.46) to ($1.54) per share. Neumora Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.

Neumora Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/6/2024
(Estimated)
------- 
5/7/2024Q1 2024($0.34)($0.34)-($0.34)--
3/7/2024Q4 2023($0.76)($0.71)+$0.05($0.71)--
11/1/2023Q3 2023($0.35)($1.14)($0.79)($1.14)--

Neumora Therapeutics Earnings - Frequently Asked Questions

When is Neumora Therapeutics's earnings date?

Neumora Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on NMRA's earnings history.

Did Neumora Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Neumora Therapeutics (NASDAQ:NMRA) reported ($0.34) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.34). Learn more on analysts' earnings estimate vs. NMRA's actual earnings.

How much profit does Neumora Therapeutics generate each year?

Neumora Therapeutics (NASDAQ:NMRA) has a recorded net income of -$235.93 million. NMRA has generated $0.00 earnings per share over the last four quarters.

What is Neumora Therapeutics's EPS forecast for next year?

Neumora Therapeutics's earnings are expected to decrease from ($1.46) per share to ($1.54) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:NMRA) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners